A Safety and Efficacy Study of DRL-17822, a Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Patients With Abnormal Cholesterol Levels

Clinical trial NCT01388816 · COMPLETED

Trial details

NCT number: NCT01388816
Sponsor: Dr. Reddy's Laboratories Limited
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Type II Hyperlipidemia

Start date: 2011-07-01
Primary completion: 2012-05-01
Enrollment: 176

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.